Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

about

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

P2860

Q52639397-67D023F1-9F18-464B-B7C5-9CEC7CAEC73D Q58803309-5A9ED3A8-D4C0-4FF0-ABDC-0A4CB8D910EE

P2860

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

Item

http://www.wikidata.org/entity/Q37709763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Spotlight on blisibimod and it ...... rythematosus: evidence to date

@en

Spotlight on blisibimod and it ...... ythematosus: evidence to date.

@nl

type

Item

label

Spotlight on blisibimod and it ...... rythematosus: evidence to date

@en

Spotlight on blisibimod and it ...... ythematosus: evidence to date.

@nl

prefLabel

Spotlight on blisibimod and it ...... rythematosus: evidence to date

@en

Spotlight on blisibimod and it ...... ythematosus: evidence to date.

@nl

P1476

Spotlight on blisibimod and it ...... rythematosus: evidence to date

@en

P2093

Aleksander Lenert

http://www.w3.org/2001/XMLSchema#string

Petar Lenert

http://www.w3.org/2001/XMLSchema#string

Timothy B Niewold

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

B-cell survival factors in autoimmune rheumatic disorders

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

Ligand-receptor binding revealed by the TNF family member TALL-1

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

P304

747-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S114552

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28331294

http://www.w3.org/2001/XMLSchema#string

P921

systemic lupus erythematosus

recombinant protein

P932

5357079

http://www.w3.org/2001/XMLSchema#string

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

about

P2860

P2860

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932